openPR Logo
Press release

Cancer Monoclonal Antibodies Market Overview, Trends, Opportunities, Growth and Forecast by 2027

01-17-2023 02:02 PM CET | Health & Medicine

Press release from: IMARC Group

Cancer Monoclonal Antibodies Market

Cancer Monoclonal Antibodies Market

IMARC Group's latest report, titled "Cancer Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global cancer monoclonal antibodies market size reached US$ 42.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 55.2 Billion by 2027, exhibiting a growth rate (CAGR) of 4.9% during 2022-2027.

Cancer monoclonal antibodies are a type of antibody that is widely utilized in the treatment of cancer. They are laboratory-produced antibodies that are meant to specifically target and bind to cancer cells and aid in detecting cancer, delivering treatments, or helping the body recognize and destroy cancer cells. Additionally, they are generally well-tolerated and have fewer side effects than chemotherapy and radiation. As a result, they are employed alone or in combination with other therapies, including chemotherapy and radiation, to treat different types of cancer, including lymphoma, leukemia, and solid tumors. Some of the most commonly used monoclonal antibodies include chimeric, humanized, and murine antibodies that are employed to treat cancers in the liver, breast, brain, and blood.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/cancer-monoclonal-antibodies-market/requestsample

Competitive Landscape with Key Players:

• AbbVie Inc
• Amgen Inc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Genmab A/S
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co. Inc
• Novartis AG
• Pfizer Inc
• Roche Holding AG
• Seattle Genetics Inc
• Spectrum Pharmaceuticals Inc

Cancer Monoclonal Antibodies Market Demand:

The growing incidences of cancer among the masses majorly drive the global market. Along with this, the rising demand for targeted therapy that reduces the side effects of traditional chemotherapies is significantly supporting the market. In addition, the increasing application of cancer monoclonal antibodies in clinical trials is also driving the overall demand for cancer monoclonal antibodies. Since monoclonal antibodies are widely used for clinical trials and extensive research and development (R&D) activities are acting as another growth-inducing factor. Apart from this, several pharmaceutical companies and government institutions heavily investing in the development of novel monoclonal antibodies are providing a thrust to the market. Moreover, the launching of novel monoclonal antibodies targeting cancer-specific antigens and antibody-drug conjugates is creating a positive market outlook.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/cancer-monoclonal-antibodies-market

Key Market Segmentation:

Breakup by Antibody Type:

• Murine Antibodies
• Chimeric Antibodies
• Humanized Antibodies
• Others

Breakup by Medication Type:

• Bevacizumab (Avastin)
• Rituximab (Rituxan)
• Trastuzumab (Herceptin)
• Cetuximab (Erbitux)
• Panitumumab (Vectibix)
• Others

Breakup by Application:

• Breast Cancer
• Blood Cancer
• Liver Cancer
• Brain Cancer
• Colorectal Cancer
• Others

Breakup by End-User:

• Hospitals and Clinics
• Pharmacies
• Research Laboratories
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Research Reports:

https://www.einnews.com/pr_news/578632711/smart-air-purifiers-market-2022-share-size-growth-analysis-price-and-research-report-2027

https://www.einnews.com/pr_news/578624920/e-commerce-logistics-market-2022-global-forecast-share-size-statistics-top-companies-and-report-by-2027

https://www.einnews.com/pr_news/578624194/office-supplies-market-2022-industry-trends-analysis-growth-share-size-top-companies-and-report-2027

https://www.einnews.com/pr_news/578632711/smart-air-purifiers-market-2022-share-size-growth-analysis-price-and-research-report-2027

https://www.einnews.com/pr_news/578634504/bone-graft-and-substitutes-market-2022-global-share-report-size-growth-trends-top-companies-and-forecast-2027

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Monoclonal Antibodies Market Overview, Trends, Opportunities, Growth and Forecast by 2027 here

News-ID: 2887041 • Views:

More Releases from IMARC Group

Global Cellulose Prices Q2 2025 - Trend, News & Insights
Global Cellulose Prices Q2 2025 - Trend, News & Insights
North America Cellulose Prices Movement Q2 Cellulose Prices in United States: In Q2 2025, US Cellulose Prices were pressured by reduced output at pulp mills due to maintenance and labor shortages. Timber harvesting delays from adverse weather constrained raw material supply. Steady demand from packaging and construction supported consumption, while rising fuel surcharges and logistics costs added to overall pricing challenges. Get the Real-Time Prices Analysis: https://www.imarcgroup.com/cellulose-pricing-report/requestsample APAC Cellulose Prices Movement Q2: Cellulose Prices in
E-Waste Manufacturing Plant Report 2025: Raw Materials Requirement, Setup Cost and Revenue
E-Waste Manufacturing Plant Report 2025: Raw Materials Requirement, Setup Cost a …
E-Waste refers to discarded electronic devices such as computers, smartphones, televisions, and household appliances that have reached the end of their life cycle. It contains both valuable materials like gold, copper, and rare earth elements, as well as hazardous substances such as lead, mercury, and cadmium, making proper recycling crucial for environmental safety and resource recovery. Setting up an e-waste recycling plant requires investment in land, machinery for dismantling and extraction,
Cement Bricks Manufacturing Plant Report 2025: Business Plan, and Setup Details
Cement Bricks Manufacturing Plant Report 2025: Business Plan, and Setup Details
Cement bricks are solid or hollow rectangular blocks made from a mixture of cement, sand, and aggregates, molded and cured for strength and durability. They are widely used in construction due to their uniform shape, load-bearing capacity, resistance to fire and weather, and cost-effectiveness compared to traditional clay bricks. Setting up a cement bricks manufacturing plant involves securing land, installing machinery like mixers and molding units, sourcing raw materials, and employing
Propyl Cyanoacetate Production Cost Report 2025: Detailed Guide on Plant Setup, CapEx/OpEx and Profitability
Propyl Cyanoacetate Production Cost Report 2025: Detailed Guide on Plant Setup, …
Setting up a propyl cyanoacetate production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Propyl Cyanoacetate Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a propyl cyanoacetate

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For